Halozyme Therapeutics, Inc.
- Halozyme Therapeutics Announces Submission of Investigational New Drug Application - June 30, 2005
- Halozyme Therapeutics Files NDA for Enhanze SC - March 28, 2005
Drugs Associated with Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Generic name: hyaluronidase
Drug class: miscellaneous uncategorized agents
|3 reviews||4.0 / 10|
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|